Fludrocortisone: Difference between revisions
ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: Corticosteroid *Dosage Forms: *Routes of Administration: PO *Common Trade Names: ==Adult Dosing== *0.1 mg 3 times per week to 0.2 mg daily ==P...") |
(Text replacement - "* " to "*") |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: [[Corticosteroid]] | *Type: [[Corticosteroid]] | ||
*Dosage Forms: | *Dosage Forms: 0.1 mg oral tablets | ||
*Routes of Administration: PO | *Routes of Administration: PO | ||
*Common Trade Names: | *Common Trade Names: Florinef (note: brand discontinued in US) | ||
==Adult Dosing== | ==Adult Dosing== | ||
*0.1 mg 3 times per week to 0.2 mg daily | *Adrenal Insufficiency | ||
**0.1 mg 3 times per week to 0.2 mg daily. Give with food or milk. Taper dose gradually to d/c. | |||
*Orthostatic Hypotension | |||
**0.1 mg PO qD initially then may increase by 0.1 mg/d weekly up to a max of 1 mg/d (>0.5 mg rarely helpful). Taper dose gradually to d/c. | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
''NOT FDA approved in children'' | |||
*0.05-0.2 mg/day | *0.05-0.2 mg/day | ||
| Line 39: | Line 42: | ||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: 3.5 hours | *Half-life: 3.5 hours | ||
*Metabolism: Hepatic | *Metabolism: Hepatic, kidney | ||
*Excretion: | *Excretion: urine | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Latest revision as of 01:13, 24 July 2017
Administration
- Type: Corticosteroid
- Dosage Forms: 0.1 mg oral tablets
- Routes of Administration: PO
- Common Trade Names: Florinef (note: brand discontinued in US)
Adult Dosing
- Adrenal Insufficiency
- 0.1 mg 3 times per week to 0.2 mg daily. Give with food or milk. Taper dose gradually to d/c.
- Orthostatic Hypotension
- 0.1 mg PO qD initially then may increase by 0.1 mg/d weekly up to a max of 1 mg/d (>0.5 mg rarely helpful). Taper dose gradually to d/c.
Pediatric Dosing
NOT FDA approved in children
- 0.05-0.2 mg/day
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing: no adjustment
- Hepatic dosing: no adjustment
Contraindications
- Allergy to class/drug
- Systemic fungal infections
Adverse Reactions
Serious
- Secondary adrenal insufficiency
- Elevated ICP, seizure
- CHF, cardiomegaly, hypertension
- Thrombophlebitis
Common
- Bruising, petechiae
- Impaired wound healing
- Hyperglycemia, hypokalemia
- Rash, urticaria
- Peptic ulcer disease
- Irregular menses, growth delay (children)
- Headache, vertigo
Pharmacology
- Half-life: 3.5 hours
- Metabolism: Hepatic, kidney
- Excretion: urine
Mechanism of Action
- Very potent mineralocorticoid, also has glucocorticoid effects